ERGOCALCIFEROL Solution for injection Ref.[8405] Active ingredients: Vitamin D2

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2015  Publisher: RPH Pharmaceuticals AB, Lagervägen 7, 136 50, Haninge, Sweden

Product name and form

Ergocalciferol Injection BP 300,000U.

Pharmaceutical Form

Solution for Injection.

Qualitative and quantitative composition

Ergocalciferol BP 0.75% W/V.

For excipients see 6.1.

Active Ingredient Description
Vitamin D2

Vitamin D2 (ergocalciferol) is a fat soluble vitamin. In conjunction with parathyroid hormone and calcitonin, it regulates calcium haemostasis. Ergocalciferol metabolites promote active absorption of calcium and phosphorous by the small intestine, increase rate of excretion and resorption of minerals in bone and promote resorption of minerals in bone and promote resorption of phosphate by renal tubules.
List of Excipients

Ethyl oleate

Pack sizes and marketing

1ml clear, one-point cut (OPC) glass Type 1 Ph Eur ampoules packed in cartons of 10 ampoules

Marketing authorization holder

RPH Pharmaceuticals AB, Lagervägen 7, 136 50, Haninge, Sweden

Marketing authorization dates and numbers

PL 36301/0008

04/04/2006

 
Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈